Belinda E Butcher

17PUBLICATIONS
66CO-AUTHORS
Gene and molecular therapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Toxicology (incl. clinical toxicology)Recordkeeping informatics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 22, 2026
Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 ALLG MM23 (SeaLAND) trial.

|Sep 20, 2026
Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.

|Sep 03, 2024
Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study.

Emma Verner, Amanda Johnston, Nalini Pati

|Mar 08, 2024
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia.

Geoffrey Littlejohn, Joanna Leadbetter, Belinda E Butcher

|Mar 01, 2023
Registry randomised trials: a methodological perspective.

Dorota A Doherty, Steven Y C Tong, Jennifer Reilly

|Jun 20, 2022
Attitudes of Australian breast cancer patients toward the secondary use of administrative and clinical trial data.

Elizabeth Hutchings, Belinda E Butcher, Phyllis Butow

Pageof 3

Frequent Collaborators

4 joint publications

Geoffrey Littlejohn

4 joint publications

Tegan Smith

4 joint publications

Hedley Griffiths

3 joint publications

Catherine O'Sullivan